(2026). Real-world efficacy of lenvatinib/pembrolizumab combination in anaplastic thyroid carcinoma: Case series from two Italian referral centers. European Thyroid Journal.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Real-world Efficacy of Lenvatinib/pembrolizumab Combination in Anaplastic Thyroid Carcinoma: Case Series from Two Italian Referral Centers."
European Thyroid Journal 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Real-world Efficacy of Lenvatinib/pembrolizumab Combination in Anaplastic Thyroid Carcinoma: Case Series from Two Italian Referral Centers."
European Thyroid Journal, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.